Mousavi Seyyed Mojtaba, Hashemi Seyyed Alireza, Fallahi Nezhad Fatemeh, Binazadeh Mojtaba, Dehdashtijahromi Milad, Omidifar Navid, Ghahramani Yasamin, Lai Chin Wei, Chiang Wei-Hung, Gholami Ahmad
Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan.
Nanomaterials and Polymer Nanocomposites Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada.
Materials (Basel). 2023 Jun 29;16(13):4685. doi: 10.3390/ma16134685.
Metal-organic frameworks (MOFs) have proven to be very effective carriers for drug delivery in various biological applications. In recent years, the development of hybrid nanostructures has made significant progress, including developing an innovative MOF-loaded nanocomposite with a highly porous structure and low toxicity that can be used to fabricate core-shell nanocomposites by combining complementary materials. This review study discusses using MOF materials in cancer treatment, imaging, and antibacterial effects, focusing on oral cancer cells. For patients with oral cancer, we offer a regular program for accurately designing and producing various anticancer and antibacterial agents to achieve maximum effectiveness and the lowest side effects. Also, we want to ensure that the anticancer agent works optimally and has as few side effects as possible before it is tested in vitro and in vivo. It is also essential that new anticancer drugs for cancer treatment are tested for efficacy and safety before they go into further research.
金属有机框架(MOFs)已被证明在各种生物应用中是非常有效的药物递送载体。近年来,杂化纳米结构的发展取得了重大进展,包括开发一种具有高度多孔结构和低毒性的创新型负载MOF的纳米复合材料,该材料可通过结合互补材料用于制备核壳纳米复合材料。本综述研究讨论了MOF材料在癌症治疗、成像和抗菌作用中的应用,重点关注口腔癌细胞。对于口腔癌患者,我们提供一个常规方案,用于精确设计和生产各种抗癌和抗菌剂,以实现最大疗效和最低副作用。此外,我们希望确保抗癌剂在体外和体内测试之前能最佳发挥作用且副作用尽可能少。同样重要的是,用于癌症治疗的新型抗癌药物在进入进一步研究之前要进行疗效和安全性测试。
Materials (Basel). 2023-6-29
Pharmaceuticals (Basel). 2022-9-12
Anticancer Agents Med Chem. 2021
ACS Appl Mater Interfaces. 2018-5-3
Eur J Med Chem. 2022-12-15
Compr Rev Food Sci Food Saf. 2020-7
Curr Med Chem. 2020
ACS Appl Mater Interfaces. 2023-5-17
Cell Biol Toxicol. 2025-8-1
Polymers (Basel). 2024-4-2
Pharmaceuticals (Basel). 2023-12-21
J Funct Biomater. 2022-11-3
Polymers (Basel). 2022-11-3
Pharmaceuticals (Basel). 2022-9-12
Int J Mol Sci. 2022-8-20
Int J Mol Sci. 2022-4-18